Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry ; day:25 ; month:4 ; year:2022 ; pages:1-17
Rheumatology and therapy ; (25.4.2022), 1-17
- Creator
-
Moreno-Ramos, Manuel José
Sanchez-Piedra, Carlos
Martínez-González, Olga
Rodríguez-Lozano, Carlos
Pérez-Garcia, Carolina
Freire, Mercedes
Campos, Cristina
Cáliz-Caliz, Rafael
Calvo, Jerusalem
Blanco-Madrigal, Juan María
Pérez-Gómez, Ana
Moreno-Martínez, María José
Linares, Luis
Sánchez-Alonso, Fernando
Sastré, Carlos
Castrejón, Isabel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-022-00446-9
- URN
-
urn:nbn:de:101:1-2022070720010425591774
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moreno-Ramos, Manuel José
- Sanchez-Piedra, Carlos
- Martínez-González, Olga
- Rodríguez-Lozano, Carlos
- Pérez-Garcia, Carolina
- Freire, Mercedes
- Campos, Cristina
- Cáliz-Caliz, Rafael
- Calvo, Jerusalem
- Blanco-Madrigal, Juan María
- Pérez-Gómez, Ana
- Moreno-Martínez, María José
- Linares, Luis
- Sánchez-Alonso, Fernando
- Sastré, Carlos
- Castrejón, Isabel
- SpringerLink (Online service)
Other Objects (12)
Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis
Secukinumab: A Review in Psoriatic Arthritis
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy
Secukinumab: A New Treatment Option for Psoriatic Arthritis
Correction to: Secukinumab: A Review in Psoriatic Arthritis
Work Disability in Axial Spondyloarthritis
Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients
Secukinumab (nicht röntgenologische axiale Spondyloarthritis) : Nutzenbewertung gemäß § 35a SGB V
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis
P190: Cardiovascular Disease in Axial Spondyloarthritis
Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis
Secukinumab: A Review in Psoriatic Arthritis
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy
Secukinumab: A New Treatment Option for Psoriatic Arthritis
Correction to: Secukinumab: A Review in Psoriatic Arthritis
Work Disability in Axial Spondyloarthritis
Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients
Secukinumab (nicht röntgenologische axiale Spondyloarthritis) : Nutzenbewertung gemäß § 35a SGB V
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis
P190: Cardiovascular Disease in Axial Spondyloarthritis
Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis
Secukinumab: A Review in Psoriatic Arthritis
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy
Secukinumab: A New Treatment Option for Psoriatic Arthritis
Correction to: Secukinumab: A Review in Psoriatic Arthritis
Work Disability in Axial Spondyloarthritis
Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients
Secukinumab (nicht röntgenologische axiale Spondyloarthritis) : Nutzenbewertung gemäß § 35a SGB V
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis